OmniAb, Inc. (OABI)
NASDAQ·Healthcare·Biotechnology
$1.37
-2.50%
Mkt Cap $221.94M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+193.0%
Consensus $4.00 vs current $1.37
NASDAQ·Healthcare·Biotechnology
$1.37
-2.50%
Mkt Cap $221.94M
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
+193.0%
Consensus $4.00 vs current $1.37